EsoCap announced that Sven Hoffmann and Isabelle Racamier have been appointed to the Company’s Board of Directors.
“I am delighted to welcome Isabelle and Sven to the EsoCap Board. Both of them are highly talented executives bringing deep industry experience and a proven track record of building value” said Dr. Werner Tschollar, Chairman of the Board of EsoCap.
Sven Hoffmann is a Commercial Lawyer in Basel. He started his career at F. Hoffmann-La Roche & Co. Ltd. in marketing and held various positions in its Pharmaceutical Divisions with posts in Buenos Aires, Argentina, in Lima, Peru and finally as Regional Manager of the Pharmaceutical Division in China, South-East Asia and Hong Kong. In 1992, he founded his own law firm, and has since been active as a member of a variety of Board of Directors and Board of Trustees among them Chairman of Sallfort Privatbank AG, Member of the Board of Directors of MTIP MedTech Innovation Partners AG, Chairman of the Board of Trustees of Save the Children Switzerland, Member of the Board of Trustees of ITG International Takhi Group, Member of the Board of Trustees of W.A. de Vigier Foundation.
“I couldn’t be more pleased to welcome Sven in the Board of Directors of EsoCap,” said Dr. Werner Tschollar, Chairman of the Board of EsoCap. “Sven is a world-class manager who has distinguished himself in the biopharmaceutical industry. He brings deep experience to deliver long-term shareholder value.”
“As a member of the Board of Directors,” said Sven Hoffmann, “I look forward to work with the leadership team to build upon the company’s strong innovation and drive shareholder value.”
Isabelle Racamier is Chief Executive Officer of EsoCap AG. Isabelle Racamier is an accomplished healthcare executive in the biopharmaceutical industry. Isabelle Racamier has 25 years of experience in the pharmaceutical and biotechnology industries, in controlling, strategic planning, marketing and general management. Isabelle Racamier has held increasingly responsible positions in France, Switzerland, the USA, Japan and Austria with Novartis, Boehringer Mannheim (now part of Roche) and Sanofi. She was the General Manager of Sanofi in Austria from 1998 to 2005, consistently generating yearly double-digit growth during this time. Since 2016 Isabelle Racamier is a Board member of Genomic Vision, a molecular diagnostic company listed on the French stock exchange. Isabelle Racamier earned her Master’s in Management from ESCP-Europe in Paris. She received executive training in Marketing at INSEAD.
Dr. Tschollar stated: “I am extremely pleased that Isabelle joined EsoCap earlier as a CEO and is now additionally appointed as a Board Member. She brings to EsoCap a strong track record of managing major organizations and is recognized for delivering high-performance.”
“EsoCap is an exciting company,” said Isabelle Racamier, “with significant innovation to build upon to deliver considerable value in the biopharmaceutical industry. I look forward to further contributing to EsoCap’s future as a member of the Board of Directors.”